Below are some of the studies that the NRS Neuroprogressive Disease and Dementia Network have been involved in
CHIEF-PD
The UK’s largest study using cholinesterase inhibitors to reduce falls in Parkinson’s patients.
Exenatide-PD3
Investigating Exenatide’s potential disease-modifying effects in Parkinson’s Disease.
INSIGHT
Measuring insight into memory and thinking abilities in people with dementia.
TOP HAT
Assessing the use of ondansetron for treating symptoms in Parkinson’s disease and in Lewy Body dementia
PD-COMM
The UK’s largest study investigating Speech and Language therapy for Parkinson’s.
